Becton, Dickinson and Company BDX, popularly known as BD, recently announced the launch of BD COR System, a new and fully-automated high-throughput diagnostic system utilizing robotics and sample ...
Becton, Dickinson and CompanyBDX, also known as BD, recently announced the FDA 510(k) clearance of its Phoenix CPO detect test. This will allow hospitals to identify infections caused by carbapenemase ...
FRANKLIN LAKES, N.J. and AUSTIN, Texas, Dec. 17, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company (BDX)), a leading global medical technology company, and Babson Diagnostics, a science-first ...
As the science and technology behind genomic sequencing progresses, high-throughput molecular testing has increasingly become a crucial tool in identifying diseases in their earliest stages. Despite ...
FRANKLIN LAKES, N.J., Oct. 16, 2018 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the availability of the BD MAX™ MDR-TB ...
BD Vaginal Panel on BD COR™ System Tests for Multiple Common Types of Vaginitis Using Only One Swab, One Test FRANKLIN LAKES, N.J., March 16, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company ...
BD Selects Alverix to Develop Instrumentation to Be Part of New System to Improve Infectious Disease Diagnoses at Point-of-Care When combined with existing diagnostic tests, or with assays currently ...
Achieves a ~3‑hour faster time to detection (~15% reduction) versus the prior generation system, per clinical study data,¹ enabling earlier targeted therapy. First‑of‑its‑kind blood volume measurement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results